Innovation
Economic impact from BrisSynBio’s world-class research
BrisSynBio’s industrial offering
BrisSynBio offers a wide range of industrially relevant in-house expertise, technical capability and facilities. We work closely with companies to understand their research and development needs, and have built long-term relationships with industry in a range of sectors. We are seeking further partnerships through:
Translational research
We have industrially relevant projects and intellectual property in four main areas:
-
Novel chemistry
Including natural products and novel enzymes
-
Therapeutic platforms
Including gene therapy and blood cell engineering
-
Peptide design
Self-assembling peptides with multiple applications
-
Agri-tech
Including wheat recombination
BrisSynBio aims to be a translational synthetic biology hub for Bristol and the South West. Through our Innovation Programme we aim to:
- develop a self-sustaining funding steam from BrisSynBio innovation activities
- establish BrisSynBio as a high-profile centre for synthetic biology innovation with a vibrant industrial network
- foster a long-term culture of innovation at all levels of BrisSynBio students and staff
This programme is already bearing fruit. BrisSynBio’s first start-up company (Zentraxa) was launched in early 2017 and we have a range of upcoming innovation events.
Full details of the Innovation Programme can be found in about BrisSynBio.
Contacts
Dr Andy Boyce
Innovations Manager
Dr Paul Race
Deputy-Director, Translation
Professor Keith Edwards
Deputy-Director, Translation